Breaking News Instant updates and real-time market news.

AAL

American Airlines

$26.26

0.44 (1.70%)

, BA

Boeing

$374.00

-2.86 (-0.76%)

08:39
10/09/19
10/09
08:39
10/09/19
08:39

American Airlines: Cancellations cut Q3 pretax profit by about $140M

AAL

American Airlines

$26.26

0.44 (1.70%)

BA

Boeing

$374.00

-2.86 (-0.76%)

  • 23

    Oct

  • 05

    Nov

  • 14

    Nov

AAL American Airlines
$26.26

0.44 (1.70%)

07/29/19
MACQ
07/29/19
DOWNGRADE
MACQ
Neutral
Macquarie warns about pricing pressure among airlines from Southwest competition
Macquarie analyst Susan Donofrio downgraded American Airlines (AAL), Spirit Airlines (SAVE), Hawaiian Holdings (HA), and Alaska Air (ALK) to Neutral from Outperform as part of a broader industry note, saying the competitive environment for these airlines should become "choppy" in the fall of 2019 and in 2020 as Southwest (LUV) attempts to win back market share. The analyst believes that the latter's sizable domestic scope should lead to "unit revenue softness" within the overall pricing structure, through she maintains an Outperform rating on United Airlines (UAL), Delta (DAL) and Allegiant (ALGT) given their ongoing revenue initiatives and minimal overlap with Southwest.
07/30/19
IMPC
07/30/19
NO CHANGE
Target $41
IMPC
Outperform
American Airlines undervalued despite 737 Max groundings, says Imperial Capital
Imperial Capital analyst Michael Derchin says shares of American Airlines (AAL) are undervalued despite the groundings of Boeing's (BA) 737 Max. The stock is attractive with 737 MAX issues largely priced into the stock and upside potential on unit revenues amid low expectations, Derchin tells investors in a research note. He maintains an Outperform rating on American with a $41 price target.
09/06/19
BREN
09/06/19
INITIATION
Target $35
BREN
Buy
American Airlines initiated with a Buy at Berenberg
Berenberg analyst Adrian Yanoshik started American Airlines with a Buy rating and $35 price target.
09/06/19
BREN
09/06/19
INITIATION
BREN
Berenberg says big 4 airlines can generate cash, prefers American and Delta
As previously reported, Berenberg analyst Adrian Yanoshik initiated coverage of the four largest U.S. airlines, starting American Airlines (AAL) with a Buy rating and $35 price target, Delta Air Lines (DAL) with a Buy rating and $72 price target, United Continental (UAL) with a Hold rating and $95 price target and Southwest Airlines (LUV) with a Hold rating and $57 price target. Amid market worries over both capacity growth and demand weakness, his work suggests that U.S. airlines can generate free cash flow in "all scenarios but a 9/11-scale shock," Yanoshik tells investors. He thinks airline sector valuations reflect fears, but overlook broadly stable, albeit two-tiered, returns. He would buy American with valuation at multi-year lows as he estimates that American will narrow its margin gap to peers and thinks it debt burden is misunderstood. He would also buy Delta, which Yanoshik calls "arguably the highest-quality airline."
BA Boeing
$374.00

-2.86 (-0.76%)

10/01/19
BOFA
10/01/19
DOWNGRADE
Target $80
BOFA
Underperform
Hexcel downgraded to Underperform from Buy at BofA/Merrill
BofA Merrill Lynch analyst Ronald Epstein double downgraded Hexcel (HXL) to Underperform from Buy and lowered his price target on the shares to $80 from $95, noting that Boeing's (BA) 787 is one of the company's largest aircraft programs, accounting for about 8% of total revenue. He lowered his expected sales CAGR for Hexcel for 2018-2021 to 6% from 7% as he factors in an estimate for lower 787 deliveries given what he views as "the weakest aircraft order environment since 2009," Epstein tells investors. He now forecasts 360 deliveries of 787s from 2021-2023, down from his prior call for 444 deliveries of 787 aircraft in that period.
10/01/19
JEFF
10/01/19
NO CHANGE
Target $430
JEFF
Buy
Boeing estimates trimmed on more cautious 737 Max view at Jefferies
Jefferies analyst Sheila Kahyaoglu raised her price target for Boeing to $430 from $420 while keeping a Buy rating on the shares. The analyst, who still assumes 737 MAX recertification occurs in 2019, lowered her 2019 estimate to reflect a more cautious view on the 737 MAX. She now forecast core earnings per share of $3.40 and $22.15 in 2019 and 2020, down from $5.30 and $22.85, respectively. However, Kahyaoglu believes Boeing's free cash flow outlook can sustain a rate of greater than $30 per share from 2020-2022 with advances and inventory as "moving pieces." She forecasts free cash flow per share of ~$6 in 2019, climbing to $31 in 2020 as 737 MAX inventory unwinds and the company reestablishes productivity capture.
10/02/19
BARD
10/02/19
NO CHANGE
Target $445
BARD
Outperform
Boeing price target lowered to $445 from $470 at Baird
Baird analyst Peter Arment lowered his price target on Boeing to $445 from $470 as he sees increased risk to the company's production rates over the next 24 months. The analyst does see free cash flow dynamics beginning to improve in 2020 with 2021 still looking favorable. He sees a lower valuation range more likely especially with existing China risks. Arment maintained his Outperform rating on Boeing shares.
10/08/19
BUCK
10/08/19
NO CHANGE
Target $395
BUCK
Neutral
Buckingham sticks by call for Boeing 'bounce' to $425-$450 despite EU 'friction'
Buckingham analyst Richard Safran noted that Boeing reported 787 deliveries were lighter than expected in Q3 and also noted that new press reports have raised concerns that the EU could delay MAX certification. While he thinks any potential EU action delaying MAX certification is a concern, he also thinks investors view 2019 "as a throw away year for valuation" and a delay in MAX certification from European regulators isn't likely to meaningfully change estimates for 2020 and 2021. Safran said he still believes Boeing shares could bounce to $425-$450 when there are clear signs the MAX will be returning to service, though he keeps a Neutral rating and $395 price target on the stock.

TODAY'S FREE FLY STORIES

SFBS

ServisFirst

$33.95

0.46 (1.37%)

16:06
10/21/19
10/21
16:06
10/21/19
16:06
Hot Stocks
ServisFirst boosts quarterly cash dividend by 17% »

ServisFirst Bancshares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 13

    Nov

CDNS

Cadence Design

$66.53

0.93 (1.42%)

16:06
10/21/19
10/21
16:06
10/21/19
16:06
Earnings
Cadence Design reports Q3 EPS 54c, consensus 51c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 06

    Nov

  • 19

    Nov

CFB

CrossFirst Bancshares

$12.53

0.19 (1.54%)

16:06
10/21/19
10/21
16:06
10/21/19
16:06
Earnings
CrossFirst Bancshares reports Q3 EPS 21c, consensus 19c »

Reports Q3 tangible book…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

TACO

Del Taco

$9.61

0.21 (2.23%)

16:06
10/21/19
10/21
16:06
10/21/19
16:06
Earnings
Del Taco reports Q3 adjusted EPS 10c, consensus 14c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 04

    Nov

ERJ

Embraer

$17.18

0.155 (0.91%)

16:05
10/21/19
10/21
16:05
10/21/19
16:05
Hot Stocks
Embraer signs $1.4B business jet deal with Flexjet »

Embraer announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

PBYI

Puma Biotechnology

$6.94

0.45 (6.93%)

, SGEN

Seattle Genetics

$101.06

13.64 (15.60%)

16:05
10/21/19
10/21
16:05
10/21/19
16:05
Recommendations
Puma Biotechnology, Seattle Genetics analyst commentary  »

Goldman says Seattle…

PBYI

Puma Biotechnology

$6.94

0.45 (6.93%)

SGEN

Seattle Genetics

$101.06

13.64 (15.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 07

    Dec

ABBV

AbbVie

$77.41

0.94 (1.23%)

, ACRS

Aclaris Therapeutics

$1.43

-0.175 (-10.90%)

16:05
10/21/19
10/21
16:05
10/21/19
16:05
Conference/Events
Cantor specialty pharma analyst to hold analyst/industry conference call »

Specialty Pharmaceuticals…

ABBV

AbbVie

$77.41

0.94 (1.23%)

ACRS

Aclaris Therapeutics

$1.43

-0.175 (-10.90%)

AMGN

Amgen

$202.83

0.2 (0.10%)

ANAB

AnaptysBio

$36.68

-0.37 (-1.00%)

AZN

AstraZeneca

$43.74

-0.12 (-0.27%)

DERM

Dermira

$7.36

0.19 (2.65%)

INCY

Incyte

$78.50

0.73 (0.94%)

LLY

Eli Lilly

$108.06

-0.62 (-0.57%)

MPSYY

MorphoSys

$0.00

(0.00%)

NVS

Novartis

$86.37

-0.485 (-0.56%)

PFE

Pfizer

$36.47

0.01 (0.03%)

REGN

Regeneron

$298.44

-1.65 (-0.55%)

VNDA

Vanda Pharmaceuticals

$13.59

0.015 (0.11%)

XBIT

XBiotech

$9.78

0.35 (3.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 22

    Oct

  • 23

    Oct

  • 24

    Oct

  • 29

    Oct

  • 29

    Oct

  • 29

    Oct

  • 01

    Nov

  • 05

    Nov

  • 06

    Nov

  • 06

    Nov

  • 18

    Nov

  • 07

    Dec

MFSF

MutualFirst Financial

$31.02

(0.00%)

16:05
10/21/19
10/21
16:05
10/21/19
16:05
Hot Stocks
MutualFirst reports tangible book value $23.15 as of September 30 »

The Company's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMTD

TD Ameritrade

$37.81

1.02 (2.77%)

16:04
10/21/19
10/21
16:04
10/21/19
16:04
Hot Stocks
TD Ameritrade reports Q4 net new client assets $93B, up 7% from last year »

Reports Q4 average client…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

MFSF

MutualFirst Financial

$31.02

(0.00%)

16:03
10/21/19
10/21
16:03
10/21/19
16:03
Earnings
MutualFirst Financial reports Q3 EPS 71c, consensus 66c »

Reports Q3 provision for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SFBS

ServisFirst

$33.97

0.48 (1.43%)

16:03
10/21/19
10/21
16:03
10/21/19
16:03
Earnings
ServisFirst reports Q3 EPS 69c, consensus 65c »

Net interest income was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 13

    Nov

CLBK

Columbia Financial

$16.40

0.3 (1.86%)

16:02
10/21/19
10/21
16:02
10/21/19
16:02
Hot Stocks
Columbia Financial approved for acquisition of Stewardship Financial »

Columbia Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMTD

TD Ameritrade

$37.81

1.02 (2.77%)

16:02
10/21/19
10/21
16:02
10/21/19
16:02
Earnings
TD Ameritrade reports Q4 EPS $1.05, consensus 98c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

VRTX

Vertex

$183.73

7.49 (4.25%)

15:58
10/21/19
10/21
15:58
10/21/19
15:58
Hot Stocks
Vertex announces FDA approval of Trikafta for treatment of cystic fibrosis »

Vertex Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

WE

We Company

$0.00

(0.00%)

, SFTBF

SoftBank

$0.00

(0.00%)

15:42
10/21/19
10/21
15:42
10/21/19
15:42
Periodicals
SoftBank near deal to take control of WeWork, CNBC reports »

Softbank (SFTBF) is near…

WE

We Company

$0.00

(0.00%)

SFTBF

SoftBank

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTR

Frontier Communications

$1.02

0.01 (1.00%)

15:38
10/21/19
10/21
15:38
10/21/19
15:38
Hot Stocks
Frontier reports tentative agreement with CWA in Connecticut »

Frontier Communications…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

LOGI

Logitech

$40.77

0.71 (1.77%)

15:34
10/21/19
10/21
15:34
10/21/19
15:34
Options
Logitech options imply 8.8% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 04

    Nov

  • 05

    Nov

PCG

PG&E

$8.07

0.3 (3.86%)

15:20
10/21/19
10/21
15:20
10/21/19
15:20
Periodicals
San Jose would like to see PG&E become electric and gas cooperative, WSJ says »

San Jose is proposing to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Nov

  • 10

    Nov

  • 12

    Nov

  • 07

    Jan

ZION

Zions Bancorp

$45.51

0.79 (1.77%)

15:19
10/21/19
10/21
15:19
10/21/19
15:19
Options
Zions Bancorp options imply 4.0% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
10/21/19
10/21
15:17
10/21/19
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PCG

PG&E

$8.06

0.29 (3.73%)

15:16
10/21/19
10/21
15:16
10/21/19
15:16
Periodicals
San Jose proposes PG&E be customer-owned, likely to face opposition, WSJ says »

San Jose, the largest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Nov

  • 10

    Nov

  • 12

    Nov

  • 07

    Jan

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
10/21/19
10/21
15:16
10/21/19
15:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COTY

Coty

$11.47

1.345 (13.29%)

15:06
10/21/19
10/21
15:06
10/21/19
15:06
Recommendations
Coty analyst commentary  »

Coty price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

  • 06

    Nov

  • 12

    Nov

MCD

McDonald's

$210.35

1.87 (0.90%)

, UBER

Uber

$31.31

-0.73 (-2.28%)

15:05
10/21/19
10/21
15:05
10/21/19
15:05
Earnings
Fly Intel: What to watch in McDonald's earnings report »

McDonald's (MCD) is…

MCD

McDonald's

$210.35

1.87 (0.90%)

UBER

Uber

$31.31

-0.73 (-2.28%)

GRUB

GrubHub

$56.13

0.33 (0.59%)

BYND

Beyond Meat

$110.06

0.13 (0.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 28

    Oct

  • 29

    Oct

  • 04

    Nov

  • 12

    Nov

  • 19

    Nov

  • 21

    Nov

  • 04

    Dec

CDNS

Cadence Design

$66.25

0.65 (0.99%)

15:04
10/21/19
10/21
15:04
10/21/19
15:04
Options
Cadence Design options imply 7.9% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 06

    Nov

  • 19

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.